← Back to Search

Behavioral Intervention

Hula for Cognitive Impairment (NEAR Trial)

N/A
Recruiting
Led By Joseph K Kaholokula, PhD
Research Sponsored by University of Hawaii
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ages 50+ but not older than 75
Has a diagnosis of hypertension, diabetes, dyslipidemia, or obesity (body-mass-index ≥ 30 kg/m2)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months, 8 months, 12 months
Awards & highlights

NEAR Trial Summary

This trial will test whether a hula-based intervention can improve vascular risk factors, cognitive function, and complaints over 12 months in people with or at risk for ADRD.

Who is the study for?
This trial is for Native Hawaiians or other Pacific Islanders aged 50-75 with cognitive complaints, who are physically able to do moderate exercise like Hula. They must have hypertension, diabetes, high cholesterol, or obesity and a doctor's approval to participate. It's not for those already doing Hula weekly, pregnant women, people with Alzheimer's disease or severe depression.Check my eligibility
What is being tested?
The study tests if a hula-based physical activity can improve vascular risk factors and cognitive function over a year in participants with subjective cognitive impairment (SCI) or mild cognitive impairment (MCI).See study design
What are the potential side effects?
Since the intervention involves physical activity through Hula dancing, potential side effects may include muscle soreness or strain. However, these activities are generally considered safe when performed within one's physical limits.

NEAR Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 50 and 75 years old.
Select...
I have been diagnosed with high blood pressure, diabetes, high cholesterol, or obesity.

NEAR Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months, 8 months, 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months, 8 months, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in participants' Cognitive Change Index score at each time frame from baseline
Change in participants' Hemoglobin A1c at each time frame from baseline
Change in participants' Number Symbol Coding Test score at each time frame from baseline
+5 more

NEAR Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention groupExperimental Treatment1 Intervention
The intervention group will immediately receive the Ola Mau i ka Hula intervention after randomization for 12 months. The intervention program is 8 months with a 4 month self-monitoring period.
Group II: Wait-list control groupActive Control1 Intervention
After baseline data collection, participants randomized to the wait-list control arm will not receive the Ola Mau i ka Hula Program while their counterparts who were randomized to the intervention arm are undergoing the intervention program. Thus, they will not be offered the intervention until after the intervention arm is completed and their 12-month follow-up data collection is completed. They will only receive the educational component of the intervention from us during this 12-month period but they will be instructed to continue with their routine medical care as usual. Wait-list control group will be offered the opportunity to receive intervention at the conclusion of 12 month assessment period, regardless of whether they were retained for the full 12 months of data collection.

Find a Location

Who is running the clinical trial?

University of HawaiiLead Sponsor
114 Previous Clinical Trials
54,437 Total Patients Enrolled
Joseph K Kaholokula, PhDPrincipal InvestigatorUniversity of Hawaii
5 Previous Clinical Trials
1,092 Total Patients Enrolled

Media Library

Ola Mau i ka Hula (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05534607 — N/A
Mild Cognitive Impairment Research Study Groups: Intervention group, Wait-list control group
Ola Mau i ka Hula (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05534607 — N/A
Mild Cognitive Impairment Clinical Trial 2023: Ola Mau i ka Hula Highlights & Side Effects. Trial Name: NCT05534607 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any existing openings for participants in this trial?

"Affirmative, the information located on clinicaltrials.gov clarifies that this medical study is actively enlisting participants. It was initially published on September 15th 2022 and last revised a week later. 192 patients must be recruited from 3 separate sites."

Answered by AI

What is the scope of individuals engaged with this clinical trial?

"Affirmative. Clinicaltrials.gov presents proof that this clinical trial is actively recruiting participants, having first been posted on September 15th 2022 and last updated on the 7th of the same month. The researchers are looking to enrol 192 patients across 3 different medical facilities."

Answered by AI

Who fulfills the criteria to join this research project?

"This medical study is looking to enrol 192 individuals aged between 50 and 75 who have some degree of cognitive impairment. Furthermore, the participants must be Native Hawaiian or Pacific Islanders, diagnosed with hypertension, diabetes, dyslipidemia or obesity (BMI≥30kg/m2), cleared for moderate physical activity by a physician and willing to engage in such activities as part of the Hula protocol."

Answered by AI

Can adults aged 25 or above participate in this investigation?

"This research project is open to individuals aged 50 and above, up until the age of 75."

Answered by AI

Who else is applying?

What state do they live in?
Pennsylvania
What portion of applicants met pre-screening criteria?
Did not meet criteria
What site did they apply to?
Kokua Kalihi Valley

Why did patients apply to this trial?

~81 spots leftby Apr 2025